Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v5-EN Version v4-FR
Language English French
Date Updated 2021-05-07 2021-05-06
Drug Identification Number 02493373 02493373
Brand name TOUJEO DOUBLESTAR TOUJEO DOUBLESTAR
Common or Proper name Toujeo DoubleStar Toujeo DoubleStar
Company Name SANOFI-AVENTIS CANADA INC SANOFI-AVENTIS CANADA INC
Ingredients INSULIN GLARGINE INSULIN GLARGINE
Strength(s) 300UNIT 300UNIT
Dosage form(s) SOLUTION SOLUTION
Route of administration SUBCUTANEOUS SUBCUTANEOUS SUBCUTANEOUS SUBCUTANEOUS
Packaging size 3 3
ATC code A10AE A10AE
ATC description INSULINS AND ANALOGUES INSULINS AND ANALOGUES
Reason for shortage Other (Please describe in comments) Other (Please describe in comments)
Anticipated start date 2021-05-07 2021-05-07
Actual start date 2021-05-06 2021-05-06
Estimated end date 2021-06-02 2021-06-02
Actual end date
Shortage status Actual shortage Anticipated shortage
Company comments Transportation delay - The transportation delay is due to the strike at the Montreal Port. Availability dates at individual distributor warehouses may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date. Transportation delay - The transportation delay is due to the strike at the Montreal Port. Availability dates at individual distributor warehouses may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date.
Health Canada comments